| A Study of Zilovertamab Vedotin (MK-2140) as Monotherapy and in Combination in Participants With Aggressive and Indolent B-cell Malignancies (MK-2140-006) (NCT05458297) | Merck Sharp & Dohme LLC | 2022-07-21 |
| Clinical Study of Mitoxantrone Hydrochloride Liposome Injection in Subjects With Acute Myeloid Leukemia (NCT05522192) | Hui Zeng | 2022-07-21 |
| A Study of Sapanisertib in Relapsed/Refractory NFE2L2-Mutated and Wild-Type Squamous Non-Small Cell Lung Cancer (NCT05275673) | Faeth Therapeutics | 2022-07-21 |
| Vudalimab for the Treatment of Locally Advanced or Metastatic Anaplastic Thyroid Cancer or Hurthle Cell Thyroid Cancer (NCT05453799) | Northwestern University | 2022-07-21 |
| Anti-tumour Activity of (177Lu) rhPSMA-10.1 Injection (NCT05413850) | Blue Earth Therapeutics Ltd | 2022-07-20 |
| A Study of LY3561774 in Participants With Mixed Dyslipidemia (NCT05256654) | Eli Lilly and Company | 2022-07-20 |
| A Study of Cabozantinib as a Maintenance Agent to Prevent Progression or Recurrence in High-Risk Pediatric Solid Tumors (NCT05135975) | Nationwide Children's Hospital | 2022-07-20 |
| A Study to Evaluate the Antiviral Activity and Safety of HH-003 in Chronic Hepatitis B Subjects With Low-level Viremia (NCT05734807) | Huahui Health | 2022-07-20 |
| mFOLFOX6 Combined With Dalpiciclib in Patients With Metastatic Colorectal Cancer (NCT05480280) | Sixth Affiliated Hospital, Sun Yat-sen University | 2022-07-20 |
| A Study of Nipocalimab in Children Aged 2 to Less Than 18 Years With Generalized Myasthenia Gravis (NCT05265273) | Janssen Research & Development, LLC | 2022-07-20 |
| Combined Steroid and Cyclosporin as First-line Treatment in Adults With Primary Immune Thrombocytopenia (NCT05459649) | Peking University People's Hospital | 2022-07-20 |
| Treatment of Advanced or Metastatic Triple-negative Breast Cancer With Adoptive Therapy of PD1+ TILS (NCT05451784) | Fundacio Clinic Barcelona | 2022-07-20 |
| Transoral Surgical Resection Followed by De-escalated Adjuvant IMRT in Resectable p16+ Locally Advanced Oropharynx Cancer (NCT05388773) | Heath Skinner | 2022-07-20 |
| Social Determinants and a Diabetes Prevention Program Tailored for African Americans (NCT05301413) | University of Missouri, Kansas City | 2022-07-20 |
| Safety, Tolerability and Pharmacodynamics Evaluation of CBT-009 Eye Drop (NCT05372991) | Cloudbreak Therapeutics, LLC | 2022-07-20 |
| Recombinant Human Angioendostatin /PD-1 Mab Combined With First-line Chemotherapy in the Treatment of Driver Gene Negative Advanced NSCLC (NCT05448781) | Affiliated Cancer Hospital & Institute of Guangzhou Medical University | 2022-07-20 |
| A Study to Investigate the Efficacy and Safety of an Infusion of IOV-4001 in Adult Participants With Unresectable or Metastatic Melanoma or Stage III or IV Non-small-cell Lung Cancer (NCT05361174) | Iovance Biotherapeutics, Inc. | 2022-07-20 |
| CO2 Modulation in Endovascular Thrombectomy for Acute Ischemic Stroke (NCT05051397) | University Hospital, Clermont-Ferrand | 2022-07-20 |
| Tranilast as a Radiosensitizer in Reradiation of Nasopharyngeal Carcinoma (NCT05626829) | Jian Guan | 2022-07-20 |
| Translating Metabolic Responses to Mechanical Insult Into Early Interventions to Prevent PTOA (NCT04589611) | J L Marsh | 2022-07-20 |
| Repurposing the Antipsychotic Drug Chlorpromazine as Adjuvant Therapeutic Agent for Resected Stage III Colon Cancer (NCT05433402) | Sadat City University | 2022-07-20 |
| NEOadjuvant PembRolizumab In Stratified Medicine - ColoRectal Cancer (NCT05197322) | University College, London | 2022-07-20 |
| The Effectiveness and Safety of 4% Sodium Citrate as a Lock Solution in Central Venous Hemodialysis Catheter (NCT05188339) | Chang Gung Memorial Hospital | 2022-07-20 |
| Study of PLK1 Inhibitor, Onvansertib, in Relapsed Small Cell Lung Cancer (NCT05450965) | University of Maryland, Baltimore | 2022-07-19 |
| Randomised Study to Investigate the Effectiveness of Acupuncture for the Relief of Long COVID-19 Related Fatigue (NCT05212688) | Royal Marsden NHS Foundation Trust | 2022-07-19 |
| A Randomized, Double-Blind, Placebo-Controlled, Multi-Center, Phase II Trail Evaluating the Efficacy and Safety of GR1802 Injection in Patients with Moderate to Severe Asthma (NCT06642961) | Genrix (Shanghai) Biopharmaceutical Co., Ltd. | 2022-07-19 |
| Maintenance Belantamab Mafodotin (Blenrep®) After B-cell Maturation Antigen-Directed Chimeric Antigen Receptor T-cell Therapy in Patients With Relapsed and/or Refractory Multiple Myeloma (NCT05117008) | Medical College of Wisconsin | 2022-07-19 |
| Photobiomodulation and Glass Ionomer Sealant as Complementary Treatment for Hypersensitivity in Molars With MIH (NCT05370417) | University of Nove de Julho | 2022-07-19 |
| Plerixafor in Acute Respiratory Distress Syndrome Related to COVID-19 (Phase IIb) (NCT05411575) | 4Living Biotech | 2022-07-19 |
| A Study to Evaluate Safety and Efficacy of KM-819 in Healthy Adults and Participants with Parkinson's Disease (NCT05670782) | FAScinate Therapeutics Inc. | 2022-07-19 |
| Testing the Addition of Nivolumab to Standard Treatment for Patients With Metastatic or Unresectable Colorectal Cancer That Have a BRAF Mutation (NCT05308446) | National Cancer Institute (NCI) | 2022-07-19 |
| Treatment of Acute PTH With a CGRP Receptor mAb in Military Service Members and Civilians With mTBI (NCT05049057) | Henry M. Jackson Foundation for the Advancement of Military Medicine | 2022-07-19 |
| ET140203 T Cells in Pediatric Subjects With Hepatoblastoma, HCN-NOS, or Hepatocellular Carcinoma (NCT04634357) | Eureka Therapeutics Inc. | 2022-07-19 |
| Sub-study of Belantamab Mafodotin (GSK2857916) in Combination With Nirogacestat, Lenalidomide, and Dexamethasone in Participants With RRMM (NCT07150091) | GlaxoSmithKline | 2022-07-19 |
| First-in-human Study of DB-1305/BNT325 for Advanced/Metastatic Solid Tumors (NCT05438329) | DualityBio Inc. | 2022-07-19 |
| Managing Agitated Delirium With Neuroleptics and Anti-Epileptics as a Neuroleptic Sparing Strategy (NCT05431595) | M.D. Anderson Cancer Center | 2022-07-19 |
| Xenon MRI and Progressive ILD (NCT05241275) | Duke University | 2022-07-19 |
| Safety and Pharmacokinetics Study of a Modified Tafasitamab IV Dosing Regimen Combined With Lenalidomide in R-R DLBCL Patients (NCT05222555) | Incyte Corporation | 2022-07-19 |
| A Study to Evaluate RIST4721 in Hidradenitis Suppurativa (HS) (NCT05348681) | Aristea Therapeutics, Inc. | 2022-07-18 |
| Orthofeet: A Prospective Proof of Concept Trial to Evaluate an Innovative Pain Relief Footwear (NCT05434078) | Bijan Najafi, PhD | 2022-07-18 |
| Beta-glucan and Immune Response to Influenza Vaccine (NCT05074303) | University of Florida | 2022-07-18 |
| Assess Safety and Efficacy of VAD044 in HHT Patients (NCT05406362) | Vaderis Therapeutics AG | 2022-07-18 |
| Istradefylline for Parkinson Disease With Cognitive Impairment (NCT05333549) | Virginia Commonwealth University | 2022-07-18 |
| Study to Compare Feasibility of 1-step Injectable Artesunate vs. Conventional 2-step Injectable Artesunate (NCT05140278) | University of Oxford | 2022-07-18 |
| Dual Anti-CD22/CD19 Chimeric Antigen Receptor-directed T Cells (CART2219.1) for Relapsed Refractory B-Lineage Leukaemia (NCT05429905) | KK Women's and Children's Hospital | 2022-07-18 |
| Getting SMART for Pediatric Epilepsy (NCT05439876) | National Taiwan University Hospital | 2022-07-18 |
| Mechanisms of a Dynamic Stability Approach (NCT05247398) | University of Minnesota | 2022-07-18 |
| A Study to Evaluate Safety and Immunogenicity of One or Two Booster Vaccinations With H5N6 Influenza Vaccine in Adults Primed With H5N1 Influenza Vaccine or Unprimed (NCT05422326) | Seqirus | 2022-07-18 |
| Tislelizumab Combined With XELOX as Neoadjuvant Therapy for G/GEJ Adenocarcinoma (NCT05507658) | Xijing Hospital | 2022-07-18 |
| A Study to Evaluate the Efficacy and Safety of ZX-7101A Tablets in Adults with Uncomplicated Influenza (NCT05702489) | Nanjing Zenshine Pharmaceuticals | 2022-07-17 |
| PD-1 Inhibitor Plus GP as Neoadjuvant Therapy for Locoregionally Advanced Nasopharyngeal Carcinoma (NCT05340270) | Guangxi Medical University | 2022-07-15 |
| Efficacy and Safety Study of Thymosin Beta 4 in Patients With Acute Myocardial Infarction (NCT05984134) | Beijing Northland Biotech. Co., Ltd. | 2022-07-15 |
| Annatto-derived GG for Statin-associated Myopathy (NCT05312424) | Texas Tech University Health Sciences Center | 2022-07-15 |
| Open-label, Pivotal Clinical Trial to Confirm Efficacy and Safety of Autologous Grafts Containing Stem Cells Genetically Modified for Epidermis Restoration in Patients With Junctional Epidermolysis Bullosa (NCT05111600) | Holostem s.r.l. | 2022-07-15 |
| Zimberelimab Combined With Concurrent Radiotherapy and Chemotherapy for Locally Advanced Cervical Cancer (NCT05437692) | Shanghai Zhongshan Hospital | 2022-07-15 |
| Effect of Probiotic Supplement on Improvement of Depressive Symptoms in Patients With Substance-Induced Depressive Disorder (NCT06790823) | Shiraz University of Medical Sciences | 2022-07-15 |
| SVRd for the Treatment of Newly Diagnosed Multiple Myeloma Patients Presenting With Extramedullary Disease (NCT05900882) | The First Affiliated Hospital with Nanjing Medical University | 2022-07-15 |
| Entecavir Prophylaxis for Hepatitis B Reactivation for CD20 Positive B-cell Lymphoma Patients With Resolved Hepatitis B (Negative Hepatitis B Surface Antigen, Positive Hepatitis B Core Antibody) (NCT05453435) | Sun Yat-sen University | 2022-07-15 |
| Immunosurveillance for Metastatic Colorectal Cancer (NCT06509880) | MIPO Clinic | 2022-07-15 |
| Cryoablation Combined With Tislelizumab Plus Lenvatinib in Patients With Melanoma Liver Metastasis (NCT05406466) | Fudan University | 2022-07-15 |
| Anti-PD-1 Antibody Combined With Autologous DC and NK Cells in the Treatment of Digestive Carcinoma (NCT05461235) | China Medical University, China | 2022-07-15 |
| Phase II Clinical Study to Evaluate the Efficacy and Safety of HLX07+HLX10 +mFOLFOX6 or HLX07 Monotherapy in Patients With mCRC (NCT05239650) | Shanghai Henlius Biotech | 2022-07-15 |
| Study of Anitocabtagene-autoleucel in Relapsed or Refractory Multiple Myeloma (iMMagine-1) (NCT05396885) | Kite, A Gilead Company | 2022-07-15 |
| Personalized Ultrasonic Brain Stimulation for Depression (NCT05301036) | University of Utah | 2022-07-15 |
| The Clinical Trial of Low Dose Irradiation for Alzheimer's Disease (NCT05635968) | Kyung Hee University Hospital at Gangdong | 2022-07-15 |
| Mosunetuzumab With Lenalidomide Augmentation as First-line Therapy for Follicular and Marginal Zone Lymphoma (NCT04792502) | Brown University | 2022-07-14 |
| Cabazitaxel in Combination With 177Lu-PSMA-617 in Metastatic Castration-resistant Prostate Cancer (NCT05340374) | Peter MacCallum Cancer Centre, Australia | 2022-07-14 |
| A Study of GZR18 Injection in Chinese Obese/Overweight Patients (NCT06256536) | Gan and Lee Pharmaceuticals, USA | 2022-07-14 |
| A Study of Zilovertamab Vedotin (MK-2140) in Combination With Cyclophosphamide, Doxorubicin, and Prednisone Plus Rituximab or Rituximab Biosimilar (Truxima) (R-CHP) in Participants With Diffuse Large B-Cell Lymphoma (DLBCL) (MK-2140-007) (NCT05406401) | Merck Sharp & Dohme LLC | 2022-07-14 |
| Bedaquiline Enhanced Post ExpOsure Prophylaxis for Leprosy (Phase 2) (NCT05406479) | Institute of Tropical Medicine, Belgium | 2022-07-14 |
| Efficacy and Safety of Baricitinib in Sjogren's Syndrome (NCT05016297) | Peking Union Medical College Hospital | 2022-07-14 |
| A Study in Subjects With Retinitis Pigmentosa (NCT05392179) | Aldeyra Therapeutics, Inc. | 2022-07-14 |
| A Prospective, Multi-Centre Trial of TKI Redifferentiation Therapy in Patients With RAIR Thyroid Cancer (I-FIRST Study) (NCT05182931) | Olivia Newton-John Cancer Research Institute | 2022-07-14 |
| Palliative RadIotherapy of Multiple Metastatic Sites Before First Line of Systemic Therapy With Immune Checkpoint Inhibitors and Chemotherapy in Metastatic Non-Small-Cell Lung Cancer (NCT05440916) | University Medical Centre Maribor | 2022-07-14 |
| ASCT in Combination With C-CAR088 for Treating Patients With Ultra High-risk Multiple Myeloma (MM) (NCT05632380) | Institute of Hematology & Blood Diseases Hospital, China | 2022-07-14 |
| Quick Epidural Top-up With Alkalinized Lidocaine for Emergent Caesarean Delivery (NCT05313256) | University Hospital, Bordeaux | 2022-07-14 |
| A Study to Evaluate the Safety and Efficacy of Cotadutide Given by Subcutaneous Injection in Adult Participants With Non-cirrhotic Non-alcoholic Steatohepatitis With Fibrosis (NCT05364931) | AstraZeneca | 2022-07-14 |
| A Study of [177Lu]Lu-DOTA-TATE in Newly Diagnosed ES-SCLC Patients in Combination With Carboplatin, Etoposide and Atezolizumab (NCT05142696) | Novartis Pharmaceuticals | 2022-07-13 |
| GnRHa + Letrozole in Obese Progestin-insensitive Endometrial Atypical Hyperplasia Patients (NCT06390904) | Xiaojun Chen | 2022-07-13 |
| A Single Arm Phase 2 Study to Evaluate Efficacy and Safety of Trastuzumab Deruxtecan for Patients With HER2 Mutant NSCLC (NCT05246514) | AstraZeneca | 2022-07-13 |
| sFOLFOXIRI in Advanced Gastroesophageal Cancer, (SAGE) (NCT05332002) | Rutgers, The State University of New Jersey | 2022-07-13 |
| A Study of DR-01 in Subjects With Large Granular Lymphocytic Leukemia or Cytotoxic Lymphomas (NCT05475925) | Dren Bio | 2022-07-13 |
| A Study of LBP-EC01 in the Treatment of Acute Uncomplicated UTI Caused by Drug Resistant E. Coli (ELIMINATE Trial) (NCT05488340) | Locus Biosciences | 2022-07-13 |
| Sotorasib in KRAS G12C Mutated, Resectable, Stage Ib-IIIA NSCLC (NCT05400577) | Fox Chase Cancer Center | 2022-07-13 |
| Imaging Evaluation of PLN-74809 in Participants With IPF (PLN-74809) (NCT05621252) | Pliant Therapeutics, Inc. | 2022-07-13 |
| Baricitinib for Steroid-resistant/Relapse Immune Thrombocytopenia (NCT05446831) | Peking University People's Hospital | 2022-07-13 |
| GnRHa + Letrozole in Obese Progestin-insensitive Endometrial Cancer Patients (NCT06379113) | Xiaojun Chen | 2022-07-13 |
| Testing the Safety and Efficacy of the Addition of a New Anti-cancer Drug, ZEN003694, to Chemotherapy Treatment (Cisplatin and Etoposide or Carboplatin and Paclitaxel) for Adult and Pediatric Patients (12-17 Years) With NUT Carcinoma (NCT05019716) | National Cancer Institute (NCI) | 2022-07-13 |
| GnRHa + Letrozole in Non-obese Progestin-insensitive Endometrial Cancer and Atypical Hyperplasia Patients (NCT05316935) | Xiaojun Chen | 2022-07-13 |
| Tislelizumab Plus Cetuximab and Irinotecan vs Third-line Standard-of-care in Refractory mCRC (NCT05278351) | Shanghai Zhongshan Hospital | 2022-07-13 |
| Pembrolizumab in Muscle-invasive Bladder Cancer (NCT05406713) | Matthew Galsky | 2022-07-13 |
| Surgery Combined With Maintenance Targeted Therapy in the Treatment of Advanced Ovarian Cancer (NCT05200260) | Shanghai Gynecologic Oncology Group | 2022-07-13 |
| A Study of Cytisinicline for Vaping Cessation in Adult Smokers (NCT05431387) | Achieve Life Sciences | 2022-07-13 |
| Satralizumab in the Treatment of Pulmonary Arterial Hypertension (SATISFY-JP Trial) (NCT05679570) | International University of Health and Welfare | 2022-07-12 |
| Tinzaparin And Biomarkers After Neoadjuvant Treatment of Ovarian Cancer (NCT05284552) | University Hospital, Linkoeping | 2022-07-12 |
| Extension Study to Evaluate How Safe and Tolerable NBI-921352 is as an Adjunctive Therapy for Participants With SCN8A-DEE (NCT05226780) | Neurocrine Biosciences | 2022-07-12 |
| Sintilimab Combined With IBI310 and Surufatinib for the Treatment of G3-NET and NEC (NESSIE) (NCT05165407) | Peking University | 2022-07-12 |
| Fluorescence-guided Surgery Using cRGD-ZW800-1 in Oral Cancer (NCT04191460) | Erasmus Medical Center | 2022-07-12 |
| Bryophyllum Pinnatum Treatment of Anxiety Related to Signs of Preterm Birth (NCT05110599) | Christian Haslinger | 2022-07-12 |
| Human BCMA Targeted T Cells Injection（BCMA CAR-T）for Subjects With R/R MM (NCT05594797) | Hrain Biotechnology Co., Ltd. | 2022-07-12 |